The Patent Finder
GL

Gambro Lundia AB

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

415 patents currently held

37 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
23 more records may belong here and await a decision; they are not counted.

The next US patent term in the Gambro Lundia AB portfolio ends in Dec 2026, and more of its terms end in 2034 (44) than in any other year. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
94
Ending by 2030
Dec 2026
Next term end
313
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Blood Volume Controller During Fluid Removal US 8,556,846
Cited by 64 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Ends Jul 2027 · High confidence
Also notable
Systems and Methods for Peritoneal Dialysis Having Point of Use Dialysis Fluid Preparation Including Mixing and Heating Therefore US 10,828,412
Cited by 31 later US patents, top 10% of utility patents granted in 2020 in our data. Protection runs to 2038.
Ends Oct 2038 · High confidence
Also notable
Degassing Device and End-Cap Assembly for a Filter Including Such a Degassing Device US 8,048,209
Cited by 43 later US patents, top 25% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Ends Apr 2027 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 4 fees due Dec 11 to 30, 2026 · next Dec 11
  • 4 fees due Jan 4 to 23, 2027 · next Jan 4
  • 10 fees due Feb 1 to 28, 2027 · next Feb 1
  • 6 fees due Mar 3 to 29, 2027 · next Mar 3
  • 8 fees due Apr 8 to 29, 2027 · next Apr 8
  • 5 fees due May 5 to 26, 2027 · next May 5
  • 5 fees due Jun 3 to 29, 2027 · next Jun 3
  • 5 fees due Jul 2 to 30, 2027 · next Jul 2
  • 5 fees due Aug 6 to 25, 2027 · next Aug 6
  • 9 fees due Sep 5 to 30, 2027 · next Sep 5
  • 11 fees due Oct 2 to 23, 2027 · next Oct 2
  • 3 fees due Nov 7 to 12, 2027 · next Nov 7

Which patents, and when each one lapses · Pro

Recent changes

  • Sep 24Assignment recorded on 1 record: Buck, Reinhold and 3 others to Gambro Lundia AB Recorded Sep 24, 2026, executed Jul 20, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76134, frame 92.
  • 5 of the patents on this record were granted since Aug 24, 2026
  • 3 terms have ended since Aug 24, 2026

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 7,914,049Hydraulic Connector and a Hydraulic Circuit Incorporating the Connector
In force
 · High confidence
In forceHigh confidence
US 7,935,258Process and an Apparatus for Filling And/Or Rinsing an Extracorporeal Blood Circuit
In force
 · High confidence
In forceHigh confidence
US 8,136,675Perm Selective Asymmetric Hollow Fibre Membrane for the Separation of Toxic Mediators from Blood
In force
 · High confidence
In forceHigh confidence
US 8,048,209Degassing Device and End-Cap Assembly for a Filter Including Such a Degassing Device
In force
 · High confidence
In forceHigh confidence
US 7,875,168Device for Calculating Blood Flow in an Extracorporeal Blood Circuit, and an Apparatus for Treatment of Blood Using the Device
In force
 · High confidence
In forceHigh confidence
US 9,364,604Extracorporeal Blood Treatment Machine
In force
 · High confidence
In forceHigh confidence
US 7,922,899Medical Apparatus and Method for Setting Up a Medical Apparatus
In force
 · High confidence
In forceHigh confidence
US 8,105,260Machine and Procedure for Extracorporeal Treatment of Blood
In force
 · High confidence
In forceHigh confidence
US 7,875,183Method of Removing Antibody Free Light Chains from Blood
In force
 · High confidence
In forceHigh confidence
US 9,050,421Follow-Up of the Vascular Access of a Dialyzed Patient
In force
 · High confidence
In forceHigh confidence
10 of 415 patents shown.
Pro members see all 415.
Pro members: see all 415 patents
Also on record, not counted in the 415: 37 patents in force now held by others · 170 patents ended · 115 applications pending · 82 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited